BusinessNovelion Therapeutics Strengthens Leadership Team with Appointment of Murray Stewart, M.D., as Executive Vice President, Head of R&DBy Nasdaq OMXOct 12, 2017, 1:15 PM UTC
BusinessMetreleptin and Lipodystrophy Data Presented at the International Meeting of Pediatric EndocrinologyBy Nasdaq OMXSep 15, 2017, 12:30 PM UTC
BusinessNovelion Therapeutics Announces Presentation of Metreleptin Data at American Diabetes AssociationBy Nasdaq OMXJun 12, 2017, 12:30 PM UTC
